benperidol has been researched along with Delusional Disorder in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agelink, MW; Dammers, S; Leonhardt, M; Schär, V; Zeit, T | 1 |
Bockisch, A; Hahn, K; Hiemke, C; Nickel, O; Schlegel, S; Schlösser, R | 1 |
Bockisch, A; Hahn, K; Hiemke, C; Nickel, O; Rao, ML; Schlegel, S; Schlösser, R | 1 |
1 review(s) available for benperidol and Delusional Disorder
Article | Year |
---|---|
[The neuroleptic malignant syndrome].
Topics: Adult; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benperidol; Combined Modality Therapy; Diagnosis, Differential; Fluid Therapy; Haloperidol; Humans; Male; Methotrimeprazine; Neuroleptic Malignant Syndrome; Schizophrenia, Paranoid | 1995 |
2 other study(ies) available for benperidol and Delusional Disorder
Article | Year |
---|---|
Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
Topics: Adult; Antipsychotic Agents; Benperidol; Benzamides; Clozapine; Corpus Striatum; Dopamine Antagonists; Haloperidol; Humans; Iodine Radioisotopes; Male; Middle Aged; Prolactin; Prosencephalon; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia, Paranoid; Tomography, Emission-Computed, Single-Photon | 1996 |
[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benperidol; Benzamides; Bipolar Disorder; Brain; Clozapine; Corpus Striatum; Depressive Disorder, Major; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Frontal Lobe; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia, Paranoid; Tomography, Emission-Computed, Single-Photon | 1997 |